Transcription/NN
factors/NNS
in/IN
immune-mediated/JJ
disease/NN
./.

A/DT
large/JJ
amount/NN
of/IN
detailed/JJ
information/NN
about/IN
the/DT
intracellular/JJ
proteins/NNS
regulating/VBG
NF-kappa/NN
B/NN
activation/NN
and/CC
the/DT
cellular/JJ
response/NN
to/TO
NF-kappa/NN
B/NN
activation/NN
has/VBZ
emerged/VBN
recently/RB
./.
=====
Several/JJ
small/JJ
molecules/NNS
,/,
an/DT
antisense/JJ
oligonucleotide/NN
,/,
and/CC
gene/NN
therapeutic/JJ
agents/NNS
that/WDT
inhibit/VBP
NF-kappa/NN
b/NN
activation/NN
have/VBP
been/VBN
described/VBN
./.
=====
Despite/IN
this/DT
,/,
there/EX
are/VBP
still/RB
significant/JJ
gaps/NNS
in/IN
our/PRP$
understanding/NN
of/IN
this/DT
process/NN
and/CC
its/PRP$
consequences/NNS
./.
=====
In/IN
contrast/NN
,/,
the/DT
characterization/NN
of/IN
transcription/NN
factors/NNS
selectively/RB
regulating/VBG
cytokine/NN
production/NN
by/IN
CD4+/JJ
T/NN
cell/NN
subsets/NNS
is/VBZ
at/IN
a/DT
very/RB
early/JJ
stage/NN
./.
=====
Three/CD
interacting/VBG
proteins/NNS
have/VBP
recently/RB
been/VBN
shown/VBN
to/TO
contribute/VB
to/TO
subset-restricted/JJ
expression/NN
of/IN
the/DT
IL-4/NN
gene/NN
./.
=====
There/EX
are/VBP
other/JJ
elements/NNS
regulating/VBG
IL-4/NN
gene/NN
expression/NN
,/,
however/RB
,/,
and/CC
the/DT
relative/JJ
importance/NN
of/IN
these/DT
recently/RB
identified/VBN
proteins/NNS
has/VBZ
yet/RB
to/TO
be/VB
determined/VBN
./.